Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients

被引:26
作者
Jouneau, Stephane [1 ,2 ]
Rousseau, Chloe [3 ]
Lederlin, Mathieu [4 ,5 ]
Lescoat, Alain [2 ,6 ]
Kerjouan, Mallorie [1 ]
Chauvin, Pierre [1 ]
Luque-Paz, David [1 ]
Guillot, Stephanie [7 ]
Oger, Emmanuel [8 ]
Vernhet, Laurent [2 ]
Thibault, Ronan [9 ]
机构
[1] CHU Rennes, Dept Resp Med, Competence Ctr Rare Pulm Dis, Rennes, France
[2] Univ Rennes, CHU Rennes, IRSET Inst Rech Sante Environm & Travail, INSERM,EHESP,UMR S 1085, F-35000 Rennes, France
[3] Univ Rennes, Ctr Invest Clin, CHU Rennes, INSERM 1414, Rennes, France
[4] Univ Rennes, CHU Rennes, Dept Radiol, Rennes, France
[5] Univ Rennes, INSERM U1099, LTSI, Rennes, France
[6] Univ Rennes, Dept Internal Med & Clin Immunol, CHU Rennes, Rennes, France
[7] Univ Rennes, Dept Pulm Funct Testing, CHU Rennes, Rennes, France
[8] Univ Rennes, Dept Pharmacol, CHU Rennes, Rennes, France
[9] Univ Rennes, CHU Rennes, Nutr Metabolisms & Canc, NuMeCan,Nutr Unit,INSERM,INRAE, Rennes, France
关键词
Appetite; Weight; Body composition; Interstitial lung disease; Nintedanib; Pirfenidone; BODY-MASS INDEX; PHYSICAL-ACTIVITY; PIRFENIDONE; GUIDELINES; STATEMENT; TRIAL;
D O I
10.1016/j.clnu.2022.05.001
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction and aims: Malnutrition is frequent in patients with idiopathic pulmonary fibrosis (IPF). We examined the relationship between malnutrition at diagnosis and all-cause hospitalization, survival, and acute exacerbation in newly diagnosed IPF patients. Methods: In this prospective cohort study, the nutritional status of 153 consecutive newly-diagnosed IPF outpatients was evaluated by measuring body mass index (BMI), fat-free mass index (FFMI) with bioelectrical impedance analysis, and food intake with the Self Evaluation of Food Intake (SEFI)(R). Diagnosis was taken as the baseline date and malnutrition was defined as an FFMI below 17 (men) or 15 kg/m(2) (women). To determine the factors associated with all-cause hospitalization and mortality, univariate Cox regression analyses were performed and variables with P < 0.2 were included in a stepwise multivariable analysis. Results: A quarter (26%; 40/153) of the patients were suffering from malnutrition at baseline, which was more frequent (62%) in patients whose BMI was <25 kg/m(2). Patients whose baseline FFMI was low were more likely to be hospitalized (Hazard Ratio (HR) = 1.98 [95% confidence interval, 1.15; 3.41], P = 0.0139) and/or die (HR = 1.79 [1.11; 2.89], P = 0.0165), but their acute exacerbation rate was similar to that of patients with normal FFMIs. Decreased food intake (SEFI (R)<7) at baseline was associated with all-cause hospitalization (P = 0.003) and mortality (P < 0.0001) during follow-up. Baseline higher gender-age-physiology (GAP) scores (HR = 1.24 [1.01; 1.52], P = 0.0434; HR = 1.71 [1.37; 2.14], P < 0.0001, respectively), lower BMI (HR = 0.89 [0.83; 0.96], P = 0.003; HR = 0.89 [0.82; 0.96], P = 0.003), and decreased food intake (SEFI (R) score) (HR = 0.81 [0.71; 0.93], P = 0.003; HR = 0.72 [0.64; 0.81], P < 0.0001), but not FFMI, were independently associated with all-cause hospitalization and mortality rates during follow-up. Conclusions: Malnutrition and decreased food intake at IPF diagnosis are associated with all-cause hospitalization and mortality. Future studies will determine whether dedicated interventions to improve food intake and nutritional status could improve outcomes for IPF patients. (C) 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:1335 / 1342
页数:8
相关论文
共 33 条
  • [1] Body mass index and mortality in patients with idiopathic pulmonary fibrosis
    Alakhras, Mazen
    Decker, Paul A.
    Nadrous, Hassan F.
    Collazo-Clavell, Maria
    Ryu, Jay H.
    [J]. CHEST, 2007, 131 (05) : 1448 - 1453
  • [2] [Anonymous], 2017, PNEUMOLOGIE, V71, P9
  • [3] Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis
    Bahmer, Thomas
    Kirsten, Anne-Marie
    Waschki, Benjamin
    Rabe, Klaus F.
    Magnussen, Helgo
    Kirsten, Detlef
    Gramm, Marco
    Hummler, Simone
    Brunnemer, Eva
    Kreuter, Michael
    Watz, Henrik
    [J]. RESPIRATION, 2016, 91 (06) : 497 - 502
  • [4] A visual analogue scale for food intake as a screening test for malnutrition in the primary care setting: Prospective non-interventional study
    Bouette, Gwenhael
    Esvan, Maxime
    Apel, Katharina
    Thibault, Ronan
    [J]. CLINICAL NUTRITION, 2021, 40 (01) : 174 - 180
  • [5] Cederholm T, 2019, CLIN NUTR, V38, P1, DOI [10.1002/jcsm.12383, 10.1016/j.clnu.2019.02.033, 10.1016/j.clnu.2018.08.002, 10.1002/jpen.1440]
  • [6] Cottin V, 2017, REV MAL RESPIR, DOI [10.1016/j.rmr.2017.07.018.S0761-8425(17):30209-7, DOI 10.1016/J.RMR.2017.07.018.S0761-8425(17):30209-7]
  • [7] Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
    Cottin, Vincent
    Crestani, Bruno
    Valeyre, Dominique
    Wallaert, Benoit
    Cadranel, Jacques
    Dalphin, Jean-Charles
    Delaval, Philippe
    Israel-Biet, Dominique
    Kessler, Romain
    Reynaud-Gaubert, Martine
    Aguilaniu, Bernard
    Bouquillon, Benoit
    Carre, Philippe
    Danel, Claire
    Faivre, Jean-Baptiste
    Ferretti, Gilbert
    Just, Nicolas
    Kouzan, Serge
    Lebargy, Francois
    Marchand-Adam, Sylvain
    Philippe, Bruno
    Prevot, Gregoire
    Stach, Bruno
    Thivolet-Bejui, Francoise
    Cordier, Jean-Francois
    [J]. EUROPEAN RESPIRATORY REVIEW, 2014, 23 (132) : 193 - 214
  • [8] ATS statement: Guidelines for the six-minute walk test
    Crapo, RO
    Casaburi, R
    Coates, AL
    Enright, PL
    MacIntyre, NR
    McKay, RT
    Johnson, D
    Wanger, JS
    Zeballos, RJ
    Bittner, V
    Mottram, C
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) : 111 - 117
  • [9] Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON
    Crestani, Bruno
    Huggins, John T.
    Kaye, Mitchell
    Costabel, Ulrich
    Glaspole, Ian
    Ogura, Takashi
    Song, Jin Woo
    Stansen, Wibke
    Quaresma, Manuel
    Stowasser, Susanne
    Kreuter, Michael
    [J]. LANCET RESPIRATORY MEDICINE, 2019, 7 (01) : 60 - 68
  • [10] Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice
    Fletcher, Sophie V.
    Jones, Mark G.
    Renzoni, Elizabeth A.
    Parfrey, Helen
    Hoyles, Rachel K.
    Spinks, Katherine
    Kokosi, Maria
    Kwok, Apollinaris
    Warburton, Chris
    Titmuss, Vanessa
    Thillai, Muhunthan
    Simler, Nicola
    Maher, Toby M.
    Brereton, Christopher J.
    Chua, Felix
    Wells, Athol U.
    Richeldi, Luca
    Spencer, Lisa G.
    [J]. ERJ OPEN RESEARCH, 2018, 4 (04)